Matt Biegler

Stock Analyst at Oppenheimer

(n/a)

# 4,852

Out of 5,006 analysts

3

Total ratings

n/a

Success rate

-64.6%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Matt Biegler

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	OKUR OnKure Therapeutics	Maintains: Outperform	$35 → $30	$2.71	+1,007.01%	2	Mar 11, 2025
	ALLO Allogene Therapeutics	Maintains: Outperform	$11 → $10	$1.33	+651.88%	1	Nov 8, 2024

OnKure Therapeutics

Mar 11, 2025

Maintains: Outperform

Price Target: $35 → $30

Current: $2.71

Upside: +1,007.01%

Allogene Therapeutics

Nov 8, 2024

Maintains: Outperform

Price Target: $11 → $10

Current: $1.33

Upside: +651.88%